96 related articles for article (PubMed ID: 8462899)
1. Expression of alpha-smooth muscle actin in benign or malignant ovarian tumors.
Kobayashi H; Tsuruchi N; Sugihara K; Kaku T; Saito T; Kamura T; Tsukamoto N; Nakano H; Taniguchi S
Gynecol Oncol; 1993 Mar; 48(3):308-13. PubMed ID: 8462899
[TBL] [Abstract][Full Text] [Related]
2. Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density.
Emoto M; Iwasaki H; Mimura K; Kawarabayashi T; Kikuchi M
Cancer; 1997 Sep; 80(5):899-907. PubMed ID: 9307190
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining.
Mikami Y; Kiyokawa T; Moriya T; Sasano H
Histopathology; 2005 Feb; 46(2):130-6. PubMed ID: 15693884
[TBL] [Abstract][Full Text] [Related]
4. The occurrence of unusual smooth muscle bundles expressing alpha-smooth muscle actin in human intestinal atresia.
Masumoto K; Suita S; Taguchi T
J Pediatr Surg; 2003 Feb; 38(2):161-6. PubMed ID: 12596095
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.
Pujol P; Rey JM; Nirde P; Roger P; Gastaldi M; Laffargue F; Rochefort H; Maudelonde T
Cancer Res; 1998 Dec; 58(23):5367-73. PubMed ID: 9850067
[TBL] [Abstract][Full Text] [Related]
6. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
7. Expression of midkine and pleiotropin in ovarian tumors.
Nakanishi T; Kadomatsu K; Okamoto T; Tomoda Y; Muramatsu T
Obstet Gynecol; 1997 Aug; 90(2):285-90. PubMed ID: 9241309
[TBL] [Abstract][Full Text] [Related]
8. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
9. Localization of smooth-muscle markers in the ovaries of some ectothermic vertebrates.
Van Nassauw L; Harrisson F; Callebaut M
Anat Rec; 1991 Apr; 229(4):439-46. PubMed ID: 2048748
[TBL] [Abstract][Full Text] [Related]
10. Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies.
van Niekerk CC; Vooijs P; Casparie-van Velsen IJ; Poels LG
Cancer Detect Prev; 1997; 21(3):247-57. PubMed ID: 9167042
[TBL] [Abstract][Full Text] [Related]
11. Alpha-smooth muscle actin (alpha-SMA) and nestin expression in reactive astrocytes in multiple sclerosis lesions: potential regulatory role of transforming growth factor-beta 1 (TGF-beta1).
Moreels M; Vandenabeele F; Dumont D; Robben J; Lambrichts I
Neuropathol Appl Neurobiol; 2008 Oct; 34(5):532-46. PubMed ID: 18005096
[TBL] [Abstract][Full Text] [Related]
12. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray].
Luo J; Peng ZL; Yang KX; Wang H; Yang H; Dong DD; Yao XY
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):38-41. PubMed ID: 15774091
[TBL] [Abstract][Full Text] [Related]
13. Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: a role for transforming growth factor beta3.
Nakajima Y; Mironov V; Yamagishi T; Nakamura H; Markwald RR
Dev Dyn; 1997 Jul; 209(3):296-309. PubMed ID: 9215644
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD56 and WT1 in ovarian stroma and ovarian stromal tumors.
He H; Luthringer DJ; Hui P; Lau SK; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Jun; 32(6):884-90. PubMed ID: 18425046
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.
Moore DH; Michael H; Tritt R; Parsons SH; Kelley MR
Clin Cancer Res; 2000 Feb; 6(2):602-9. PubMed ID: 10690545
[TBL] [Abstract][Full Text] [Related]
16. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
[TBL] [Abstract][Full Text] [Related]
17. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle actin expression by human articular chondrocytes and their contraction of a collagen-glycosaminoglycan matrix in vitro.
Kinner B; Spector M
J Orthop Res; 2001 Mar; 19(2):233-41. PubMed ID: 11347696
[TBL] [Abstract][Full Text] [Related]
19. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary.
Bruening W; Giasson BI; Klein-Szanto AJ; Lee VM; Trojanowski JQ; Godwin AK
Cancer; 2000 May; 88(9):2154-63. PubMed ID: 10813729
[TBL] [Abstract][Full Text] [Related]
20. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
